Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-08
2006-08-08
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S184000
Reexamination Certificate
active
07087605
ABSTRACT:
The invention relates to novel 5-Ethyl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases.
REFERENCES:
patent: 4278673 (1981-07-01), Hartley et al.
patent: 19827640 (1999-12-01), None
patent: 9924433 (1999-05-01), None
patent: 0250078 (2002-06-01), None
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
See Lucas et al. Pharmacological Reviews 52 (3), 375-413, 2000.
Dyke, J.J. and Montant, J.G., “The therapeutic potential of PDE 4 inhibitors,” Exp. Opin. Invest. Drugs 8, 1301-1325 (1999).
Barnette, M. S., “PDE 4 inhibitors in asthma and chronic obstructive pulmonary disease,” Progress in Drug Research, Birkhäuser Verlag, Basel, 1999, pp. 193-229.
Alonso-Alija Cristina
Bischoff Hilmar
Burkhardt Nils
Cuthbert Nigel J.
Fitzgerald Mary F.
Balasubramanian Venkataraman
Bayer Aktiengesellschaft
LandOfFree
5-Ethyl-imidazotriazinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-Ethyl-imidazotriazinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-Ethyl-imidazotriazinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3669006